Frontiers

80 is the new 50

80 is the new 50 Research supports more aggressive treatment for colon cancer in older patients By KENDALL POWELL The patient was an 86-year-old woman, and surgeon Mark Bloomston, MD, carefully considered whether to remo ...[Read more]
Published: Oct-31-12 | 2  Comments | 0  Link to this post

Campus Connections

GREGORY B. LESINSKI, PhD, MPH, Tumor Immunologist CAMPUS CONNECTIONS OSUCCC – James researchers from disparate Ohio State colleges link up to undertake novel interdisciplinary research that can have striking clinical ...[Read more]
Published: Oct-31-12 | 2  Comments | 0  Link to this post

Bench To Bedside Fall 12

A phase I dose-escalation study of ABT-888 (veliparib) in combination with carboplatin in HER2-negative metastatic breast cancer HYPOTHESIS: Combining a DNA-damaging agent such as carboplatin with the PARP inhibitor veliparib will improve outcom ...[Read more]
Published: Oct-31-12 | 1  Comment | 0  Link to this post

Need to Know Fall12

GROWING A CURE   Five Ohio- and Indiana-based farm cooperatives have joined together to support food-based cancer research at the OSUCCC – James and at Ohio State's College of Food, Agricultural and Environmental Scie ...[Read more]
Published: Oct-30-12 | 0  Comment | 0  Link to this post

Upfront

Beating Cancer The ultimate solution to beating cancer would be to avoid it altogether. We can do that to a large degree through lifestyle changes, by minimizing environmental risks and through research that enables us to ...[Read more]
Published: Jul-19-12 | 1  Comment | 0  Link to this post

Frontline-The Researcher's Voice

Radiation Therapy for Breast Cancer Progress in clinical practice and personalizing treatment requires clinical trials By JULIA WHITE, MD, director of Breast Radiation Oncology and vice chair for Clinical Research, Department of Radiation Onc ...[Read more]
Published: Jul-19-12 | 0  Comment | 0  Link to this post

Breakthrough

CELLULAR COLLABORATION Study Shows How Normal Cells Fuel Tumor Growth MICHAEL OSTROWSKI, PhD, (right), OSUCCC – James Co-leader of the Molecular Biology and Cancer Genetics Program GUSTAVO LEONE, PhD, OSUCCC ...[Read more]
Published: Jul-19-12 | 0  Comment | 0  Link to this post

Of Note

AWARDS AND RECOGNITIONS  ​ CLARA D. BLOOMFIELD, MD, Distinguished University Professor, cancer scholar and senior adviser to the OSUCCC – James, was awarded the 2012 Richard L. Schilsky Cancer and Leukemia Group B Achievement Award ...[Read more]
Published: Jul-19-12 | 0  Comment | 0  Link to this post

<< Previous    Next >>